Compassionate and efficient Family Nurse Practitioner with over 25 years of experience in caring for patients and families with various Movement Disorders and dementia. Independently able to practice, certification by ANCC and licensed to practice in IL and MO. Vast telemedicine and EMR experience, certified in many dementia and movement disorders interviews and rating scales. Efficient and successful in navigating complex cases and ability to treat patients individually with specialized care, support, education and hand-holding.
Is Levodopa Response a Valid Indicator of Parkinson's Disease? Martin WRW, Miles M, Zhong Q, Hartlein J, Racette BA, Norris SA, Ushe M, Maiti B, Criswell S, Davis AA, Kotzbauer PT, Cairns NJ, Perrin RJ, Perlmutter JS.Mov Disord. 2021 Apr;36(4):948-954. doi: 10.1002/mds.28406. Epub 2020 Nov 30.PMID: 33253432.
Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases. Campbell MC, Markham J, Flores H, Hartlein JM, Goate AM, Cairns NJ, Videen TO, Perlmutter JS.Neurology. 2013 Aug 6;81(6):520-7. doi: 10.1212/WNL.0b013e31829e6f94. Epub 2013 Jul 3.PMID: 23825179.
A pilot study of basal ganglia and thalamus structure by high dimensional mapping in children with Tourette syndrome. Williams AC, McNeely ME, Greene DJ, Church JA, Warren SL, Hartlein JM, Schlaggar BL, Black KJ, Wang L.F1000Res. 2013 Oct 8;2:207. doi: 10.12688/f1000research.2-207.v1. eCollection 2013.PMID: 24715957.
A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease. Nichols MJ, Hartlein JM, Eicken MG, Racette BA, Black KJ.F1000Res. 2013 Jul 9;2:150. doi: 10.12688/f1000research.2-150.v1. eCollection 2013.PMID: 2462778.
Amyloid imaging of Lewy body-associated disorders. Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS.Mov Disord. 2010 Nov 15;25(15):2516-23. doi: 10.1002/mds.23393.PMID: 20922808
A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group.Mov Disord. 2010 Nov 15;25(15):2501-7. doi: 10.1002/mds.23362.PMID: 20878991.
Mapping Go-No-Go performance within the subthalamic nucleus region. Hershey T, Campbell MC, Videen TO, Lugar HM, Weaver PM, Hartlein J, Karimi M, Tabbal SD, Perlmutter JS.Brain. 2010 Dec;133(Pt 12):3625-34. doi: 10.1093/brain/awq256. Epub 2010 Sep 20.PMID: 20855421.
Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome. Wang L, Lee DY, Bailey E, Hartlein JM, Gado MH, Miller MI, Black KJ.Psychiatry Res. 2007 Feb 28;154(2):181-90. doi: 10.1016/j.pscychresns.2006.08.006. Epub 2007 Feb 7.PMID: 17289354.
Intravenous levodopa administration in humans based on a two-compartment kinetic model. Gordon M, Markham J, Hartlein JM, Koller JM, Loftin S, Black KJ.J Neurosci Methods. 2007 Jan 30;159(2):300-7. doi: 10.1016/j.jneumeth.2006.07.010. Epub 2006 Aug 24.PMID: 1693433.
Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study. Hershey T, Black KJ, Hartlein JM, Barch DM, Braver TS, Carl JL, Perlmutter JS.Biol Psychiatry. 2004 May 1;55(9):916-25. doi: 10.1016/j.biopsych.2004.01.003.PMID: 15110735.
Clinical features and comorbidity of mood fluctuations in Parkinson's disease. Racette BA, Hartlein JM, Hershey T, Mink JW, Perlmutter JS, Black KJ.J Neuropsychiatry Clin Neurosci. 2002 Fall;14(4):438-42. doi: 10.1176/jnp.14.4.438.PMID: 12426412.